Changes in body temperature of the unanaesthetized monkey produced by sodium and calcium ions perfused through the cerebral ventricles.

PubWeight™: 1.02‹?› | Rank: Top 15%

🔗 View Article (PMC 1331783)

Published in J Physiol on September 01, 1971

Authors

R D Myers, W L Veale, T L Yaksh

Articles cited by this

Electrochemical aspects of physiological and pharmacological action in excitable cells. I. The resting cell and its alteration by extrinsic factors. Pharmacol Rev (1958) 12.88

EFFECTS ON TEMPERATURE OF AMINES INJECTED INTO THE CEREBRAL VENTRICLES. A NEW CONCEPT OF TEMPERATURE REGULATION. J Physiol (1964) 7.02

Effects of changes in the external sodium and calcium concentrations on spontaneous electrical activity in smooth muscle of guinea-pig taenia coli. J Physiol (1963) 4.29

Effects of intraventricular and intrahypothalamic injection of noradrenaline and 5-HT on body temperature in conscious rabbits. J Physiol (1965) 3.96

CHANGES IN TEMPERATURE PRODUCED BY MICRO-INJECTIONS OF AMINES INTO THE ANTERIOR HYPOTHALAMUS OF CATS. J Physiol (1965) 3.56

Perfusion from cerebral ventricle to cisterna magna in the unanaesthetized cat. Effect of calcium on body temperature. J Physiol (1970) 2.73

Control of body temperature in the unanaesthetized monkey by cholinergic and aminergic systems in the hypothalamus. J Physiol (1969) 2.23

The role of sodium and calcium ions in the hypothalamus in the control of body temperature of the unanaesthetized cat. J Physiol (1971) 1.47

Body temperature: possible ionic mechanism in the hypothalamus controlling the set point. Science (1970) 1.34

Synergistic action of sodium and angiotensin on brain mechanisms controlling fluid balance. Life Sci I (1970) 1.09

Evidence for brain Na receptors controlling renal Na excretion and plasma renin activity. Am J Physiol (1970) 0.99

Effect on body temperature of perfusing calcium-free saline solution from a lateral ventricle to cisterna magna in the unanaesthetized rabbit. J Physiol (1970) 0.92

A method for perfusion of cerebral ventricles of the conscious monkey. J Appl Physiol (1971) 0.89

Serum and cerebral spinal fluid chemistry values for the monkey (Macaca mulatta). Lab Anim Care (1970) 0.88

Calcium evoked release of 5-hydroxytryptamine from the brain of the unanesthetized cat. Experientia (1970) 0.87

Articles by these authors

Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods (1994) 23.05

Analgesia mediated by a direct spinal action of narcotics. Science (1976) 2.84

Perfusion from cerebral ventricle to cisterna magna in the unanaesthetized cat. Effect of calcium on body temperature. J Physiol (1970) 2.73

Upregulation of dorsal root ganglion (alpha)2(delta) calcium channel subunit and its correlation with allodynia in spinal nerve-injured rats. J Neurosci (2001) 2.33

Control of body temperature in the unanaesthetized monkey by cholinergic and aminergic systems in the hypothalamus. J Physiol (1969) 2.23

Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat. J Pharmacol Exp Ther (1992) 2.17

Studies on the direct spinal action of narcotics in the production of analgesia in the rat. J Pharmacol Exp Ther (1977) 2.11

Appearance of 5-hydroxytryptamine and an unidentified pharmacologically active lipid acid in effluent from perfused cerebral ventricles. J Physiol (1966) 2.10

Intrathecal morphine inhibits substance P release from mammalian spinal cord in vivo. Nature (1980) 2.08

Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition. Science (1992) 2.00

Spinal opiate analgesia: characteristics and principles of action. Pain (1981) 1.97

Intrathecal somatostatin in cat and mouse studies on pain, motor behavior, and histopathology. Anesth Analg (1989) 1.96

Pharmacology of the spinal action of ketorolac, morphine, ST-91, U50488H, and L-PIA on the formalin test and an isobolographic analysis of the NSAID interaction. Anesthesiology (1993) 1.86

Pharmacology of spinal adrenergic systems which modulate spinal nociceptive processing. Pharmacol Biochem Behav (1985) 1.85

Prolonged alleviation of tactile allodynia by intravenous lidocaine in neuropathic rats. Anesthesiology (1995) 1.83

In vivo studies on spinal opiate receptor systems mediating antinociception. II. Pharmacological profiles suggesting a differential association of mu, delta and kappa receptors with visceral chemical and cutaneous thermal stimuli in the rat. J Pharmacol Exp Ther (1984) 1.83

Characterization of variables defining hindpaw withdrawal latency evoked by radiant thermal stimuli. J Neurosci Methods (1997) 1.82

Studies in the primate on the analgetic effects associated with intrathecal actions of opiates, alpha-adrenergic agonists and baclofen. Anesthesiology (1981) 1.80

Effects on temperature of monoamines injected into the cerebral ventricles of anaesthetized dogs. J Physiol (1966) 1.67

Systematic examination in the rat of brain sites sensitive to the direct application of morphine: observation of differential effects within the periaqueductal gray. Brain Res (1976) 1.66

Release of substance P from the cat spinal cord. J Physiol (1987) 1.52

Thermoregulation around a new set-point' established in the monkey by altering the ratio of sodium to calcium ions within the hypothalamus. J Physiol (1971) 1.51

Long-term spinal analgesic delivery: a review of the preclinical and clinical literature. Reg Anesth Pain Med (2000) 1.51

Efficacy of spinal NMDA receptor antagonism in formalin hyperalgesia and nerve injury evoked allodynia in the rat. J Pharmacol Exp Ther (1997) 1.50

The role of sodium and calcium ions in the hypothalamus in the control of body temperature of the unanaesthetized cat. J Physiol (1971) 1.47

Effect of continuous spinal remifentanil infusion on behaviour and spinal glutamate release evoked by subcutaneous formalin in the rat. Br J Anaesth (1998) 1.45

Role of voltage-dependent calcium channel subtypes in experimental tactile allodynia. J Pharmacol Exp Ther (1994) 1.44

Differential cross-tolerance between intrathecal morphine and sufentanil in the rat. Anesthesiology (1990) 1.42

Spinal cord pharmacology of adrenergic agonist-mediated antinociception. J Pharmacol Exp Ther (1980) 1.39

Narcotic analgestics: CNS sites and mechanisms of action as revealed by intracerebral injection techniques. Pain (1978) 1.37

The effect of spinal GABA receptor agonists on tactile allodynia in a surgically-induced neuropathic pain model in the rat. Pain (1997) 1.36

Effect of COX-1 and COX-2 inhibition on induction and maintenance of carrageenan-evoked thermal hyperalgesia in rats. J Pharmacol Exp Ther (1998) 1.36

Continuous low-dose intrathecal morphine administration in the treatment of chronic pain of malignant origin. Mayo Clin Proc (1981) 1.35

Body temperature: possible ionic mechanism in the hypothalamus controlling the set point. Science (1970) 1.34

Voltage-sensitive calcium channels in spinal nociceptive processing: blockade of N- and P-type channels inhibits formalin-induced nociception. J Neurosci (1994) 1.34

Intrathecal capsaicin depletes substance P in the rat spinal cord and produces prolonged thermal analgesia. Science (1979) 1.33

The physiology and pharmacology of spinal opiates. Annu Rev Pharmacol Toxicol (1985) 1.31

Tactile allodynia and formalin hyperalgesia in streptozotocin-diabetic rats: effects of insulin, aldose reductase inhibition and lidocaine. Pain (1996) 1.27

Cardiorespiratory and spinal cord blood flow effects of intrathecal neostigmine methylsulfate, clonidine, and their combination in sheep. Anesthesiology (1995) 1.26

Spinal nitric oxide synthesis inhibition blocks NMDA-induced thermal hyperalgesia and produces antinociception in the formalin test in rats. Pain (1993) 1.26

Analgetic actions of intrathecal opiates in cat and primate. Brain Res (1978) 1.24

Effect of subarachnoid gabapentin on tactile-evoked allodynia in a surgically induced neuropathic pain model in the rat. Reg Anesth (1997) 1.23

Cyclooxygenase inhibition and the spinal release of prostaglandin E2 and amino acids evoked by paw formalin injection: a microdialysis study in unanesthetized rats. J Neurosci (1995) 1.20

Antinociceptive effects of spinal cholinesterase inhibition and isobolographic analysis of the interaction with mu and alpha 2 receptor systems. Anesthesiology (1994) 1.19

Baclofen is antinociceptive in the spinal intrathecal space of animals. Eur J Pharmacol (1978) 1.19

Serotonin and thermoregulation: old and new views. J Physiol (Paris) (1981) 1.18

Characterization of the pharmacology of intrathecally administered alpha-2 agonists and antagonists in rats. J Pharmacol Exp Ther (1992) 1.17

Antinociceptive effects of intrathecally injected cholinomimetic drugs in the rat and cat. Eur J Pharmacol (1985) 1.17

Spinal glial TLR4-mediated nociception and production of prostaglandin E(2) and TNF. Br J Pharmacol (2010) 1.16

Caffeine as an analgesic adjuvant: a review of pharmacology and mechanisms of action. Pharmacol Rev (1993) 1.16

Spinal monoamine and opiate systems partly mediate the antinociceptive effects produced by glutamate at brainstem sites. Brain Res (1984) 1.15

Evoked release of 5-HT and NEFA from the hypothalamus of the conscious monkey during thermoregulation. Experientia (1969) 1.15

Spinal serotonin terminal system mediates antinociception. J Pharmacol Exp Ther (1979) 1.15

Comparison of the antinociceptive effects of pre- and posttreatment with intrathecal morphine and MK801, an NMDA antagonist, on the formalin test in the rat. Anesthesiology (1992) 1.15

Effect of continuous intrathecal infusion of omega-conopeptides, N-type calcium-channel blockers, on behavior and antinociception in the formalin and hot-plate tests in rats. Pain (1995) 1.15

Spinal PKC activity and expression: role in tolerance produced by continuous spinal morphine infusion. Pain (2000) 1.14

Comparison of antinociceptive action of morphine in the periaqueductal gray, medial and paramedial medulla in rat. Brain Res (1986) 1.13

Analgesic and neurotoxic effects of intrathecal corticosteroids in rats. Anesthesiology (1994) 1.12

An extensive exploration of the rat brain for sites mediating prostaglandin-induced hyperthermia. Brain Res (1977) 1.11

Micturition in rats: a chronic model for study of bladder function and effect of anesthetics. Am J Physiol (1986) 1.10

Epidural injections of bupivacaine, morphine, fentanyl, lofentanil, and DADL in chronically implanted rats: a pharmacologic and pathologic study. Anesthesiology (1986) 1.10

Drug effects on urinary bladder tone during spinal morphine-induced inhibition of the micturition reflex in unanesthetized rats. Anesthesiology (1988) 1.10

Multiple opioid receptor systems in brain and spinal cord: Part I. Eur J Anaesthesiol (1984) 1.10

Spinal noradrenergic terminal system mediates antinociception. Brain Res (1980) 1.10

Characterization of time course of spinal amino acids, citrulline and PGE2 release after carrageenan/kaolin-induced knee joint inflammation: a chronic microdialysis study. Pain (1996) 1.09

Long-term pain relief produced by intrathecal morphine infusion in 53 patients. J Neurosurg (1990) 1.09

Direct evidence that spinal serotonin and noradrenaline terminals mediate the spinal antinociceptive effects of morphine in the periaqueductal gray. Brain Res (1979) 1.08

The pharmacokinetics of lignocaine in humans during a computer-controlled infusion. Eur J Pain (1997) 1.08

Sites of action of opiates in production of analgesia. Prog Brain Res (1988) 1.08

Intrathecal baclofen and muscimol, but not midazolam, are antinociceptive using the rat-formalin model. J Pharmacol Exp Ther (1995) 1.08

Properties of two unmyelinated fibre tracts of the central nervous system: lateral Lissauer tract, and parallel fibres of the cerebellum. J Physiol (1978) 1.07

Temperature in the monkey: transmitter factors released from the brain during thermoregulation. Science (1968) 1.07

Stereospecific effects of a nonpeptidic NK1 selective antagonist, CP-96,345: antinociception in the absence of motor dysfunction. Life Sci (1991) 1.06

Studies on the antagonism by raphe lesions of the antinociceptive action of systemic morphine. Eur J Pharmacol (1977) 1.06

Epidural ketamine: a useful, mechanistically novel adjuvant for epidural morphine? Reg Anesth (1997) 1.06

Characterization of muscarinic receptor subtypes that mediate antinociception in the rat spinal cord. Anesth Analg (1997) 1.06

Structure-antinociceptive activity of neurotensin and some novel analogues in the periaqueductal gray region of the brainstem. Brain Res (1991) 1.06

Development of GABA-sensitive spasticity and rigidity in rats after transient spinal cord ischemia: a qualitative and quantitative electrophysiological and histopathological study. Neuroscience (2006) 1.05

Antinociceptive properties of intrathecal dexmedetomidine in rats. Eur J Pharmacol (1991) 1.05

The antinociceptive effects of spinally administered neuropeptide Y in the rat: systematic studies on structure-activity relationship. J Pharmacol Exp Ther (1991) 1.04

An improved method for chronic catheterization of the rat spinal subarachnoid space. Physiol Behav (1981) 1.04

Concentration-effect relations for intravenous lidocaine infusions in human volunteers: effects on acute sensory thresholds and capsaicin-evoked hyperpathia. Anesthesiology (1997) 1.03

Drinking of high concentrations of ethanol versus palatable fluids in alcohol-preferring (P) rats: valid animal model of alcoholism. Alcohol (1991) 1.03

The effect of morphine on formalin-evoked behaviour and spinal release of excitatory amino acids and prostaglandin E2 using microdialysis in conscious rats. Br J Pharmacol (1995) 1.03

Antipyresis: its effect on mortality rate of bacterially infected rabbits. Brain Res Bull (1980) 1.03

Vincristine-induced allodynia in the rat. Pain (2001) 1.02

Pharmacology of the spinal adenosine receptor which mediates the antiallodynic action of intrathecal adenosine agonists. J Pharmacol Exp Ther (1996) 1.02

Spinal pharmacology of thermal hyperesthesia induced by constriction injury of sciatic nerve. Excitatory amino acid antagonists. Pain (1992) 1.02

Pain models display differential sensitivity to Ca2+-permeable non-NMDA glutamate receptor antagonists. Anesthesiology (2001) 1.02

Hypothermia produced by nicotine perfused through the cerabral ventricles of the unanaesthetized monkey. Neuropharmacology (1971) 1.02

Dynorphin A and related peptides administered intrathecally in the rat: a search for putative kappa opiate receptor activity. J Pharmacol Exp Ther (1986) 1.02

Intrathecal substance P-induced thermal hyperalgesia and spinal release of prostaglandin E2 and amino acids. Neuroscience (1999) 1.02

Potency of infused spinal antinociceptive agents is inversely related to magnitude of tolerance after continuous infusion. J Pharmacol Exp Ther (1989) 1.02

Isobolographic and dose-response analyses of the interaction between intrathecal mu and delta agonists: effects of naltrindole and its benzofuran analog (NTB). J Pharmacol Exp Ther (1992) 1.01

Release of vasopressin and oxytocin by paraventricular stimulation in rats. Am J Physiol (1990) 1.01